These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24192505)

  • 1. Hepatitis C infection is very rarely treated among hemodialysis patients.
    Goodkin DA; Bieber B; Gillespie B; Robinson BM; Jadoul M
    Am J Nephrol; 2013; 38(5):405-12. PubMed ID: 24192505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of hepatitis C virus infection in patients with end-stage renal disease.
    Liu CH; Kao JH
    J Gastroenterol Hepatol; 2011 Feb; 26(2):228-39. PubMed ID: 21261711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of HCV in patients with renal failure.
    Kalia H; Lopez PM; Martin P
    Arch Med Res; 2007 Aug; 38(6):628-33. PubMed ID: 17613354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus infection in end-stage renal disease and kidney transplantation.
    Burra P; Rodríguez-Castro KI; Marchini F; Bonfante L; Furian L; Ferrarese A; Zanetto A; Germani G; Russo FP; Senzolo M
    Transpl Int; 2014 Sep; 27(9):877-91. PubMed ID: 24853721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCV-positive dialysis patients awaiting a kidney transplant.
    Kamar N; Ribes D; Izopet J; Rostaing L
    Transplantation; 2006 Oct; 82(7):853-6. PubMed ID: 17038897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatitis C virus infection in renal-transplant patients].
    Kamar N; Izopet J; Ribes D; Rostaing L
    Nephrologie; 2004; 25(1):9-15. PubMed ID: 15022868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome of kidney transplantation in patients with hepatitis C virus infection.
    Huo TI; Yang WC; Wu JC; King KL; Lin CY; Loong CC; Lui WY; Chang FY; Lee SD
    Hepatogastroenterology; 2001; 48(37):169-73. PubMed ID: 11268958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of interferon for chronic hepatitis C virus-related hepatitis in kidney transplant candidates on hemodialysis: results after transplantation.
    Casanovas-Taltavull T; Baliellas C; Benasco C; Serrano TT; Casanova A; Pérez JL; Guerrero L; González MT; Andres E; Gil-Vernet S; Casais LA
    Am J Gastroenterol; 2001 Apr; 96(4):1170-7. PubMed ID: 11316166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-viral triple therapy with telaprevir in haemodialysed HCV patients: is it feasible?
    Dumortier J; Guillaud O; Gagnieu MC; Janbon B; Juillard L; Morelon E; Leroy V
    J Clin Virol; 2013 Feb; 56(2):146-9. PubMed ID: 23149155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of a common problem in hemodialysis patients: is the juice worth the squeeze?
    Al-Saran K; Sabry A; Shaheen N; Yehia A
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):876-82. PubMed ID: 19736496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan.
    Yu ML; Lin SM; Chuang WL; Dai CY; Wang JH; Lu SN; Sheen IS; Chang WY; Lee CM; Liaw YF
    Antivir Ther; 2006; 11(8):985-94. PubMed ID: 17302368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus.
    Berenguer J; Alvarez-Pellicer J; Martín PM; López-Aldeguer J; Von-Wichmann MA; Quereda C; Mallolas J; Sanz J; Tural C; Bellón JM; González-García J;
    Hepatology; 2009 Aug; 50(2):407-13. PubMed ID: 19575364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCV in patients with end-stage renal disease.
    Okoh EJ; Bucci JR; Simon JF; Harrison SA
    Am J Gastroenterol; 2008 Aug; 103(8):2123-34. PubMed ID: 18796105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C infection and the patient with end-stage renal disease.
    Fabrizi F; Poordad FF; Martin P
    Hepatology; 2002 Jul; 36(1):3-10. PubMed ID: 12085342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy for hepatitis C virus infection increases survival of patients with pretreatment anemia.
    Mohanty A; Erqou S; McGinnis KA; Vanasse G; Freiberg MS; Sherman KE; Butt AA
    Clin Gastroenterol Hepatol; 2013 Jun; 11(6):741-7.e3. PubMed ID: 23376794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon monotherapy for dialysis patients with chronic hepatitis C: an analysis of the literature on efficacy and safety.
    Russo MW; Goldsweig CD; Jacobson IM; Brown RS
    Am J Gastroenterol; 2003 Jul; 98(7):1610-5. PubMed ID: 12873587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis and HIV infection during haemodialysis.
    Saha D; Agarwal SK
    J Indian Med Assoc; 2001 Apr; 99(4):194-9, 203, 213. PubMed ID: 11666025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatitis C infection among patients receiving hemodialysis].
    Kamar N; Izopet J; Rostaing L
    Nephrologie; 2003; 24(3):133-41. PubMed ID: 12814060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus infection in haemodialysis and kidney transplant patients.
    Baid-Agrawal S; Pascual M; Moradpour D; Frei U; Tolkoff-Rubin N
    Rev Med Virol; 2008; 18(2):97-115. PubMed ID: 18064722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.